Taxpayer-Funded Drugs & A Pricing Crisis
This system enables pharmaceutical companies to turn taxpayer investment into unrestrained profit without regard to affordability or accessibility.
This system enables pharmaceutical companies to turn taxpayer investment into unrestrained profit without regard to affordability or accessibility.
P4AD Analysis of 2017 Medicare Part D Spending
How one of the world’s top-5 pharmaceutical corporations rips off America.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.